In a mouse model of ischemic stroke, Singh et al
However, for the brain hemisphere that was exposed to FUS combined with inhibitor treatment, the most profound GSK-3 down-regulation was observed when comparing with the control mice (0.21 0.06% vs
However, subcutaneous injection is the standard route for systemic and musculoskeletal effects, as it provides more reliable bioavailability and allows injection near the injury site
This nuanced approach is rarely addressed in existing literature, and it contributes a new dimension to therapeutic planning [206]
When to decrease dose Consider decreasing if: Persistent side effects that don't resolve Excellent results achieved and maintenance desired Budget constraints require conservation Stacking and wanting to optimize ratios Many researchers find they can reduce dose during maintenance phases after achieving initial goals during more intensive loading phases
doi: 10.3390/app13031571 205